Mesoblast’s allogeneic or ‘off-the-shelf’ regenerative medicine products focus on repair of damaged tissues and modulation of inflammatory responses in conditions with significant unmet medical needs.
Products
Mesoblast's strategic Mesenchymal Precursor Cell (MPC) product development focus is in three major and distinct areas:
Technologies
Mesoblast’s core technologies include its Mesenchymal Precursor Cell (MPC) technology platform for bone marrow and adipose tissue derived products, Dental Pulp Stem Cells (DPSCs) and expanded Hematopoietic Stem Cells (HSCs).